Prostaglandins for induction of second-trimester termination and intrauterine death
2003; Volume: 17; Issue: 5 Linguagem: Inglês
10.1016/s1521-6934(03)00068-3
ISSN1532-1932
AutoresSuk Wai Ngai, Oi Shan Tang, Pak Chung Ho,
Tópico(s)Maternal and Perinatal Health Interventions
ResumoThe introduction of synthetic prostaglandin has revolutionized the treatment protocol for induction of second-trimester abortion and intrauterine death. Gemeprost is the only licensed synthetic prostaglandin analogue for second-trimester abortion in the United Kingdom. However, it is expensive and needs to be stored in a refrigerator. Misoprostol is marketed for use in the prevention and treatment of peptic ulcer. It is inexpensive and can be stored at room temperature. It has been widely used for induction of second-trimester abortion and intrauterine death. Misoprostol, 400 microg given vaginally every 3hours, is probably the optimal regimen for second-trimester abortion. The combination of misoprostol and mifepristone significantly reduced the induction-to-abortion interval when compared with the misoprostol-only regimen. In addition, misoprostol can also be used as a cervical priming agent prior to dilatation and evacuation in second-trimester abortion.
Referência(s)